JDE Peet’s recognised for Diversity Excellence with 2025 Catalyst Award 12-12-2024, 22:30

Cority Continues to Be a Leader in the Sustainability Software Market, According to Prominent Industry Analyst Report 16-07-2025, 17:00

Io Therapeutics, Inc., presented today results from studies of IRX4204, the company’s phase II clinical development stage, highly selective RXR nuclear receptor agonist compound, supporting its potential use for treatment of amyotrophic lateral sclerosis 16-07-2024, 20:26